The Online Books Page

Pharmacy -- Research -- United States

See also what's at your library, or elsewhere.

• Pharmacy -- Research
• Medicine -- Research -- United States
• Pharmacy -- United States
• Research -- United States

• Pharmaceutical R&D: Costs, Risks, and Rewards (OTA-H-522; 1993), by United States Congress Office of Technology Assessment (page images at HathiTrust)

Items below (if any) are from related and broader terms.

• Computing Life (NIH publication 10-5861; 2010), by National Institute of General Medical Sciences (U.S.) (multiple formats wih commentary at NIH)
• Alternatives to Animal Use in Research, Testing, and Education (1986), by United States Congress Office of Technology Assessment (PDF files at Princeton)
• Quality of Health Care; Human Experimentation, 1973: Hearings Before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-Third Congress, First Session (4 volumes; Washington: GPO, 1973), by United States Senate Committee on Labor and Public Welfare (page images at HathiTrust)
• Recommendations for Research on the Health of Military Women: Bibliographies (1995), by Institute of Medicine (U.S.) (page images with commentary at NAP)
• Resource Sharing in Biomedical Research, ed. by Kenneth I. Berns, Enriqueta C. Bond, and Frederick J. Manning (page images and partial HTML at NAP)

• The Funding of Young Investigators in the Biological and Biomedical Sciences (1994), by National Research Council Committee on the Funding of Young Investigators in Biological and Biomedical Sciences (HTML with commentary at NAP)

• Breathing in America: Diseases, Progress, and Hope (New York: American Thoracic Society, 2010), ed. by Dean E. Schraufnagel (PDF with commentary at thoracic.org)

• Medical Bondage: Race, Gender, and the Origins of American Gynecology (Athens, GA: University of Georgia Press, c2017), by Deirdre Benia Cooper Owens (PDF at OAPEN)

• Findings (2001-) (full serial archives)

• The Allocation of Public Funds for Biomedical R&D (Washington: AEI Press, 1999), by Frank R. Lichtenberg (PDF with commentary at AEI)
• How Has Federal Research on AIDS/HIV Disease Contributed to Other Fields? (Washington: Office of Technology Assessment, 1990), by Jane E. Sisk, Maria Elizabeth Hewitt, and Paula Chludzinski
  • page images at HathiTrust
  • PDF files at Princeton

• Strengthening Research in Academic OB/GYN Departments (1992), ed. by Jessica Townsend (page images with commentary at NAP)

• Strengthening Research in Academic OB/GYN Departments (1992), ed. by Jessica Townsend (page images with commentary at NAP)

• Advisory Committee on Human Radiation Experiments: Final Report (1995), by United States Advisory Committee on Human Radiation Experiments
  • multiple formats at archive.org
  • text at National Security Archive
• Adverse Reactions to HIV Vaccines: Medical, Ethical, and Legal Issues (1995), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• Strengthening Research in Academic OB/GYN Departments (1992), ed. by Jessica Townsend (page images with commentary at NAP)

• Strengthening Research in Academic OB/GYN Departments (1992), ed. by Jessica Townsend (page images with commentary at NAP)

• A Strategy for Research in Space Biology and Medicine into the Next Century, by National Research Council Space Studies Board (page images and partial HTML at NAP)

• The Allocation of Public Funds for Biomedical R&D (Washington: AEI Press, 1999), by Frank R. Lichtenberg (PDF with commentary at AEI)

• Drug Supplies in the American Revolution (reprint from a 1961 bulletin), by George B. Griffenhagen (Gutenberg text and illustrated HTML)

• Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI)
• Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease (Washington: Office of Technology Assessment, 1992), by Alan M. Garber, Ann E. Clarke, Dana P. Goldman, and Michael E. Gluck (PDF files at Princeton)

• Fenner's Working Formulae: A Hand-Book of the Old and the New Pharmacopoeias, Containing Weight and Measure Standards, Working Processes, Working Formulae, the Medicinal Properties and Doses of Drugs and Their Preparations, and Being a Comparison of the 1870 with the 1880 Pharmacopoeia, with Remarks, Suggestions, Original Processes and Formulae, and Other Matter of Interest and Value to Druggists and Physicians (second edition; Westfield, NY: B. Fenner, c1886), by B. Fenner (page images at HathiTrust)

• Medical Technology and Costs of the Medicare Program (OTA-H-227; 1984), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files with commentary at Princeton
  • PDF at unt.edu

• Outpatient Immunosuppressive Drugs Under Medicare (OTA-H-452; 1991), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton

• Patent-Term Extension and the Pharmaceutical Industry (OTA-CIT-143; 1981), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton

• Postmarketing Surveillance of Prescription Drugs (1982), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton

• Cancer Patient Access to Unapproved Treatments: Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, Second Session, February 29, 1996 (Washington: GPO, 1996), by United States House Committee on Commerce, Subcommittee on Oversight and Investigations (page images at HathiTrust)

• The Border War on Drugs (1987), by United States Congress Office of Technology Assessment (PDF files at Princeton)
• The War on Marijuana in Black and White (with correction made Sep 2013; New York: American Civil Liberties Union, 2013), by Ezekiel Edwards, Will Bunting, and Lynda Garcia (PDF with commentary at aclu.org)
• Drug War Deadlock: The Policy Battle Continues (c2005), by Laura E. Huggins (PDF files with commentary at Hoover Institution)
• Castro and the Narcotics Connection: Special Report (original and government-derived content only; copyrighted media reports omitted; 1983), by Cuban American National Foundation (U.S.) (multiple formats at archive.org)
• Caught in the Net: The Impact of Drug Policies on Women and Families (New York: ACLU; Brennan Center for Justice; Break the Chains, ca. 2005), by Lenora M. Lapidus, Namita Luthra, Anjuli Verma, Deborah Small, Patricia E. Allard, and Kirsten D. Levingston, contrib. by Andrea J. Ritchie (PDF with commentary at brennancenter.org)
• Sea Carrier Security Manual (Washington: Dept. of the Treasury, U.S. Customs Service, Carrier Initiative Program, 1989), by U.S. Customs Service Carrier Initative Program (page images at HathiTrust)
• Agency of Fear: Opiates and Political Power in America, by Edward Jay Epstein (illustrated HTML at edwardjayepstein.com)
• Alternative Coca Reduction Strategies in the Andean Region (1993), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• Agency of Fear: Opiates and Political Power in America, by Edward Jay Epstein (illustrated HTML at edwardjayepstein.com)

• Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease (Washington: Office of Technology Assessment, 1992), by Alan M. Garber, Ann E. Clarke, Dana P. Goldman, and Michael E. Gluck (PDF files at Princeton)

• Drug Labeling in Developing Countries (1993), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• Drug Labeling in Developing Countries (1993), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• The Drug Hang-Up: America's Fifty-Year Folly, by Rufus King (HTML at druglibrary.org)

• Between Politics and Reason: The Drug Legalization Debate, by Erich Goode (HTML at druglibrary.org)

• An Offer You Can't Refuse: How US Federal Prosecutors Force Drug Defendants to Plead Guilty (New York et al.: Human Rights Watch, 2013), by Jamie Fellner (HTML and PDF with commentary at hrw.org)

• The Toadstool Millionaires: A Social History of Patent Medicines in America Before Federal Regulation, by James Harvey Young (HTML at quackwatch.com)

• Price Comparisons for Pharmaceuticals: A Review of U.S. and Cross-National Studies (Washington: AEI Press, 1999), by Patricia Munch Danzon (PDF with commentary at AEI)

• Pharmaceutical R&D: Costs, Risks, and Rewards (OTA-H-522; 1993), by United States Congress Office of Technology Assessment (page images at HathiTrust)

• American Medicinal Plants: An Illustrated and Descriptive Guide to the American Plants Used as Homoeopathic Remedies: Their History, Preparation, Chemistry and Physiological Effects (New York and Philadelphia: Boericke and Tafel, c1887), by Charles Frederick Millspaugh (multiple formats at archive.org)

• Drugs and Pharmacy in the Life of Georgia, 1733-1959 (Athens, GA: University of Georgia Press, c1959), by Robert Cumming Wilson (PDF at Georgia)

• American Journal of Pharmaceutical Education (partial serial archives)

More items available under broader and related terms at left.